These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35063774)

  • 1. Identification of ERCC8 as a novel cisplatin-resistant gene in esophageal cancer based on genome-scale CRISPR/Cas9 screening.
    Sui X; Tang X; Wu X; Liu Y
    Biochem Biophys Res Commun; 2022 Feb; 593():84-92. PubMed ID: 35063774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
    Shi S; Huang X; Ma X; Zhu X; Zhang Q
    PLoS One; 2020; 15(5):e0225290. PubMed ID: 32369495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
    Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
    Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer.
    Goodspeed A; Jean A; Costello JC
    Eur Urol; 2019 Feb; 75(2):242-250. PubMed ID: 30414698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
    Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
    lizuka N; Miyamoto K; Tangoku A; Hayashi H; Hazama S; Yoshino S; Yoshimura K; Hirose K; Yoshida H; Oka M
    Br J Cancer; 2000 Nov; 83(9):1209-15. PubMed ID: 11027435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
    Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
    Li Z; Li S; Wen Y; Chen J; Liu K; Jia J
    Technol Cancer Res Treat; 2021; 20():15330338211039127. PubMed ID: 34747666
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin.
    Skripova V; Vlasenkova R; Zhou Y; Astsaturov I; Kiyamova R
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells.
    Gao D; Hu J; Zhang X; Gao C; Hong J
    Cancer Biother Radiopharm; 2013; 28(6):433-40. PubMed ID: 23806019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
    Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
    Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of autophagy regulating chemoresistance in esophageal cancer cells.
    Fang F; Li Y; Chang L
    Exp Mol Pathol; 2020 Dec; 117():104564. PubMed ID: 33137292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K; Yang Y; Zhao J; Zhao S
    Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide screening identifies novel genes and biological processes implicated in cisplatin resistance.
    Ko T; Li S
    FASEB J; 2019 Jun; 33(6):7143-7154. PubMed ID: 30844312
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
    World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer.
    Zou FW; Yang SZ; Li WY; Liu CY; Liu XH; Hu CH; Liu ZH; Xu S
    Int J Oncol; 2020 Jul; 57(1):151-160. PubMed ID: 32319613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR‑106b‑3p increases sensitivity to cisplatin in esophageal cancer cells by targeting TGM3.
    Zhu Y; Zhang Y; Li X; Su Y; Wang N; Chen M; Yang Z
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance.
    Wang H; Wang H; Chen J; Liu P; Xiao X
    Cell Oncol (Dordr); 2024 Feb; 47(1):343-359. PubMed ID: 37672204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.